# US 2023/0287333 A1 · Production method of recombinant escherichia coli and high-purity ursodeoxycholic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0287333 A1
- Document ID: US20230287333A1
- Status: Published application
- Kind: A1
- Application number: 18/064,272
- Filed: 2022-12-11
- Published: 2023-09-14
- Earliest claimed: 2022-03-11
- Assignees: Xi'an Yueda Biotechnology Co., Ltd.
- Inventors: Tian ZHANG; Tong XUE; Lihui ZHU
- Web page: https://patentgrep.com/patent/US20230287333A1

## CPC

- C12N 1/205: Bacterial isolates
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 33/02: Dehydrogenating; Dehydroxylating
- C12R 2001/19: Escherichia coli
- C12Y 101/01047: Glucose 1-dehydrogenase (1.1.1.47)
- C12Y 101/01201: 7-Beta-hydroxysteroid dehydrogenase (NADP+) (1.1.1.201)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12Y: ENZYMES

## Abstract

The present invention belongs to the field of bioengineering technologies, and in particular, to a production method of recombinant Escherichia coli (E. coli) and high-purity ursodeoxycholic acid (UDCA). The present invention constructs novel double-enzyme co-expression gene engineered bacteria, that is, recombinant E. coli. The bacteria simultaneously expresses 7β-hydroxysteroid dehydrogenase (7β-HSDH) and glucose dehydrogenase (GDH). The bacteria is applicable to the production of high-purity UDCA. The yield of a target product is increased through the joint expression and application of 7β-HSDH and GDH. The production method of high-purity UDCA in the present invention is simple, generates a small amount of impurities in a production process, is a green process that satisfies environmental protection requirements, and has significant industrial application value.

## Claims

### Claim 1

A recombinant Escherichia coli (E. coli), wherein the recombinant E. coli simultaneously expresses 7β-hydroxysteroid dehydrogenase (7β-HSDH) and GDH.

### Claim 2 (depends on 1)

The recombinant E. coli according to claim 1, wherein the 7β-HSDH and the glucose dehydrogenase (GDH) are co-expressed by a vector pETDuet1.

### Claim 3 (depends on 1)

The recombinant E. coli according to claim 1, wherein a host bacteria of the recombinant E. coli are E. coli BL21 (DE3).

### Claim 4 (depends on 1)

The recombinant E. coli according to claim 1, wherein the recombinant E. coli is constructed by using the following method:
performing a codon optimization on genes of the 7β-HSDH and the GDH, and performing a complete gene synthesis, respectively;
first connecting the synthesized gene of the 7β-HSDH to a vector pETDuet1, to obtain a recombinant plasmid pETDuet1-7β-HSDH, and then connecting the gene of the GDH to the plasmid pETDuet1-7β-HSDH, to obtain a recombinant plasmid pETDuet1-GDH-7β-HSDH co-expressing the 7β-HSDH and the GDH;
transferring the pETDuet1-GDH-7β-HSDH into an E. coli BL21(DE3) competent cell, to obtain E. coli BL21(DE3)-pETDuet1-GDH-7β-HSDH carrying the recombinant plasmid; and
culturing the E. coli BL21(DE3)-pETDuet1-GDH-7β-HSDH, to obtain the recombinant E. coli.

### Claim 5 (depends on 4)

The recombinant E. coli according to claim 4, wherein in step (1), nucleotide sequences of the genes of the 7β-HSDH and the GDH are encoded, and the codon optimization is performed, as shown in SEQ ID NO: 1 and SEQ ID NO: 2, respectively.

### Claim 6 (depends on 4)

The recombinant E. coli according to claim 4, wherein in step (4), the culture of E. coli comprises the following steps:
inoculating the E. coli BL21(DE3)-pETDuet1-GDH-7β-HSDH into an LB solid plate culture medium for activation and culture, then picking a single colony from the LB solid plate culture medium, inoculating the single colony into an Erlenmeyer flask with an LB liquid culture medium containing 100 m g/L of ampicillin (Amp+), and performing shaking culture;
transferring the culture in step (1) into a TB liquid culture medium containing 100 m g/L of ampicillin (Amp+), performing shaking culture for a period of time, then adding 0.4 mM of isopropyl-β-D-1-thiogalactopyranoside (IPTG), and continuing with the culture; and
after induced expression ends, centrifugally collecting cells, to obtain the recombinant E. coli as engineered bacteria.

### Claim 7 (depends on 6)

The recombinant E. coli according to claim 6, wherein the LB solid plate culture medium comprises the following components: 10 g/L of tryptone, 5 g/L of yeast extract, 10 g/L of sodium chloride, and 15.0 g/L of agar; the LB liquid culture medium comprises the following components: 10 g/L of tryptone, 5 g/L of yeast extract, and 10 g/L of sodium chloride; and the TB liquid culture medium comprises the following components: 12 g/L of tryptone, 24 g/L of yeast extract, 5 g/L of glycerol, 9.4 g/L of dipotassium phosphate, and 2.2 g/L of monopotassium phosphate.

### Claim 8 (depends on 1)

A production method of high-purity ursodeoxycholic acid (UDCA), wherein production is performed by using the recombinant Escherichia coli (E. coli) according to claim 1.

### Claim 9 (depends on 8)

The production method of high-purity UDCA according to claim 8, wherein the production method is performing complete cell transformation production.

### Claim 10 (depends on 9)

The production method of high-purity UDCA according to claim 9, wherein a system of the complete cell transformation production comprises cells with a wet weight of 1 g/L to 100 g/L, 7-oxo-lithocholic acid with a concentration of 1 g/L to 200 g/L, and glucose with a concentration of 1 g/L to 100 g/L; the system has a pH of 7.0 to 9.0; and reactions occur at a condition of 1° C. to 30° C. for 1 hour to 48 hours.
